Thompson Davis & Co., Inc. Trevena Inc Transaction History

Thompson Davis & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.29 $854 - $1,935	-1,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $2,085 - $3,375	-1,500 Reduced 50.0%	1,500 $3,000
Q2 2018 Aug 03, 2018	BUY	$1.44 - $2.24 $4,320 - $6,720	3,000 New	3,000 $4,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.